Pre-order Enquiry
Request Free Sample
Global Dry Eye Disease Market Insights and Forecast to 2027
SKU ID : QYR-18102122 | Publishing Date : 26-Apr-2021 | No. of pages : 154
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Dry Eye Disease Market Insights and Forecast to 2027
1 Study Coverage1.1 Dry Eye Disease Product Introduction
1.2 Market by Type
1.2.1 Global Dry Eye Disease Market Size Growth Rate by Type
1.4.2 Artificial Tears
1.4.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dry Eye Disease Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dry Eye Disease Sales Estimates and Forecasts 2016-2027
2.2 Global Dry Eye Disease Revenue Estimates and Forecasts 2016-2027
2.3 Global Dry Eye Disease Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Dry Eye Disease Regions by Sales
2.4.1 Global Top Dry Eye Disease Regions by Sales (2016-2021)
2.4.2 Global Top Dry Eye Disease Regions by Sales (2022-2027)
2.5 Global Top Dry Eye Disease Regions by Revenue
2.5.1 Global Top Dry Eye Disease Regions by Revenue (2016-2021)
2.5.2 Global Top Dry Eye Disease Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dry Eye Disease Sales by Manufacturers
3.1.1 Global Top Dry Eye Disease Manufacturers by Sales (2016-2021)
3.1.2 Global Top Dry Eye Disease Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Dry Eye Disease Sales in 2020
3.2 Global Dry Eye Disease Revenue by Manufacturers
3.2.1 Global Top Dry Eye Disease Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Dry Eye Disease Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Dry Eye Disease Revenue in 2020
3.3 Global Dry Eye Disease Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dry Eye Disease Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dry Eye Disease Sales by Type
4.1.1 Global Dry Eye Disease Historical Sales by Type (2016-2021)
4.1.2 Global Dry Eye Disease Forecasted Sales by Type (2022-2027)
4.1.3 Global Dry Eye Disease Sales Market Share by Type (2016-2027)
4.2 Global Dry Eye Disease Revenue by Type
4.2.1 Global Dry Eye Disease Historical Revenue by Type (2016-2021)
4.2.2 Global Dry Eye Disease Forecasted Revenue by Type (2022-2027)
4.2.3 Global Dry Eye Disease Revenue Market Share by Type (2016-2027)
4.3 Global Dry Eye Disease Price by Type
4.3.1 Global Dry Eye Disease Price by Type (2016-2021)
4.3.2 Global Dry Eye Disease Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Dry Eye Disease Sales by Application
5.1.1 Global Dry Eye Disease Historical Sales by Application (2016-2021)
5.1.2 Global Dry Eye Disease Forecasted Sales by Application (2022-2027)
5.1.3 Global Dry Eye Disease Sales Market Share by Application (2016-2027)
5.2 Global Dry Eye Disease Revenue by Application
5.2.1 Global Dry Eye Disease Historical Revenue by Application (2016-2021)
5.2.2 Global Dry Eye Disease Forecasted Revenue by Application (2022-2027)
5.2.3 Global Dry Eye Disease Revenue Market Share by Application (2016-2027)
5.3 Global Dry Eye Disease Price by Application
5.3.1 Global Dry Eye Disease Price by Application (2016-2021)
5.3.2 Global Dry Eye Disease Price Forecast by Application (2022-2027)
6 North America
6.1 North America Dry Eye Disease Market Size by Type
6.1.1 North America Dry Eye Disease Sales by Type (2016-2027)
6.1.2 North America Dry Eye Disease Revenue by Type (2016-2027)
6.2 North America Dry Eye Disease Market Size by Application
6.2.1 North America Dry Eye Disease Sales by Application (2016-2027)
6.2.2 North America Dry Eye Disease Revenue by Application (2016-2027)
6.3 North America Dry Eye Disease Market Size by Country
6.3.1 North America Dry Eye Disease Sales by Country (2016-2027)
6.3.2 North America Dry Eye Disease Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dry Eye Disease Market Size by Type
7.1.1 Europe Dry Eye Disease Sales by Type (2017-2027)
7.1.2 Europe Dry Eye Disease Revenue by Type (2017-2027)
7.2 Europe Dry Eye Disease Market Size by Application
7.2.1 Europe Dry Eye Disease Sales by Application (2017-2027)
7.2.2 Europe Dry Eye Disease Revenue by Application (2017-2027)
7.3 Europe Dry Eye Disease Market Size by Country
7.3.1 Europe Dry Eye Disease Sales by Country (2017-2027)
7.3.2 Europe Dry Eye Disease Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dry Eye Disease Market Size by Type
8.1.1 Asia Pacific Dry Eye Disease Sales by Type (2018-2027)
8.1.2 Asia Pacific Dry Eye Disease Revenue by Type (2018-2027)
8.2 Asia Pacific Dry Eye Disease Market Size by Application
8.2.1 Asia Pacific Dry Eye Disease Sales by Application (2018-2027)
8.2.2 Asia Pacific Dry Eye Disease Revenue by Application (2018-2027)
8.3 Asia Pacific Dry Eye Disease Market Size by Region
8.3.1 Asia Pacific Dry Eye Disease Sales by Region (2018-2027)
8.3.2 Asia Pacific Dry Eye Disease Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dry Eye Disease Market Size by Type
9.1.1 Latin America Dry Eye Disease Sales by Type (2019-2027)
9.1.2 Latin America Dry Eye Disease Revenue by Type (2019-2027)
9.2 Latin America Dry Eye Disease Market Size by Application
9.2.1 Latin America Dry Eye Disease Sales by Application (2019-2027)
9.2.2 Latin America Dry Eye Disease Revenue by Application (2019-2027)
9.3 Latin America Dry Eye Disease Market Size by Country
9.3.1 Latin America Dry Eye Disease Sales by Country (2019-2027)
9.3.2 Latin America Dry Eye Disease Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Dry Eye Disease Market Size by Type
6.1.1 Middle East and Africa Dry Eye Disease Sales by Type (2016-2027)
6.1.2 Middle East and Africa Dry Eye Disease Revenue by Type (2016-2027)
6.2 Middle East and Africa Dry Eye Disease Market Size by Application
6.2.1 Middle East and Africa Dry Eye Disease Sales by Application (2016-2027)
6.2.2 Middle East and Africa Dry Eye Disease Revenue by Application (2016-2027)
6.3 Middle East and Africa Dry Eye Disease Market Size by Country
6.3.1 Middle East and Africa Dry Eye Disease Sales by Country (2016-2027)
6.3.2 Middle East and Africa Dry Eye Disease Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Santen Pharma
11.1.1 Santen Pharma Corporation Information
11.1.2 Santen Pharma Overview
11.1.3 Santen Pharma Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Santen Pharma Dry Eye Disease Product Description
11.1.5 Santen Pharma Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Novartis Dry Eye Disease Product Description
11.2.5 Novartis Related Developments
11.3 Llergan
11.3.1 Llergan Corporation Information
11.3.2 Llergan Overview
11.3.3 Llergan Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Llergan Dry Eye Disease Product Description
11.3.5 Llergan Related Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Overview
11.4.3 Takeda Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Takeda Dry Eye Disease Product Description
11.4.5 Takeda Related Developments
11.5 TRB Chemedica
11.5.1 TRB Chemedica Corporation Information
11.5.2 TRB Chemedica Overview
11.5.3 TRB Chemedica Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 TRB Chemedica Dry Eye Disease Product Description
11.5.5 TRB Chemedica Related Developments
11.6 Sun Pharmaceutical
11.6.1 Sun Pharmaceutical Corporation Information
11.6.2 Sun Pharmaceutical Overview
11.6.3 Sun Pharmaceutical Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Sun Pharmaceutical Dry Eye Disease Product Description
11.6.5 Sun Pharmaceutical Related Developments
11.7 Senju Pharmaceutical
11.7.1 Senju Pharmaceutical Corporation Information
11.7.2 Senju Pharmaceutical Overview
11.7.3 Senju Pharmaceutical Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Senju Pharmaceutical Dry Eye Disease Product Description
11.7.5 Senju Pharmaceutical Related Developments
11.8 Sentiss Pharma
11.8.1 Sentiss Pharma Corporation Information
11.8.2 Sentiss Pharma Overview
11.8.3 Sentiss Pharma Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sentiss Pharma Dry Eye Disease Product Description
11.8.5 Sentiss Pharma Related Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Overview
11.9.3 Johnson & Johnson Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Johnson & Johnson Dry Eye Disease Product Description
11.9.5 Johnson & Johnson Related Developments
11.10 Otsuka
11.10.1 Otsuka Corporation Information
11.10.2 Otsuka Overview
11.10.3 Otsuka Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Otsuka Dry Eye Disease Product Description
11.10.5 Otsuka Related Developments
11.1 Santen Pharma
11.1.1 Santen Pharma Corporation Information
11.1.2 Santen Pharma Overview
11.1.3 Santen Pharma Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Santen Pharma Dry Eye Disease Product Description
11.1.5 Santen Pharma Related Developments
11.12 FCI
11.12.1 FCI Corporation Information
11.12.2 FCI Overview
11.12.3 FCI Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 FCI Product Description
11.12.5 FCI Related Developments
11.13 Altacor
11.13.1 Altacor Corporation Information
11.13.2 Altacor Overview
11.13.3 Altacor Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Altacor Product Description
11.13.5 Altacor Related Developments
11.14 Valeant Pharmaceuticals
11.14.1 Valeant Pharmaceuticals Corporation Information
11.14.2 Valeant Pharmaceuticals Overview
11.14.3 Valeant Pharmaceuticals Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Valeant Pharmaceuticals Product Description
11.14.5 Valeant Pharmaceuticals Related Developments
11.15 United Laboratories
11.15.1 United Laboratories Corporation Information
11.15.2 United Laboratories Overview
11.15.3 United Laboratories Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 United Laboratories Product Description
11.15.5 United Laboratories Related Developments
11.16 Jianfeng Group
11.16.1 Jianfeng Group Corporation Information
11.16.2 Jianfeng Group Overview
11.16.3 Jianfeng Group Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Jianfeng Group Product Description
11.16.5 Jianfeng Group Related Developments
11.17 Eusan GMBH
11.17.1 Eusan GMBH Corporation Information
11.17.2 Eusan GMBH Overview
11.17.3 Eusan GMBH Dry Eye Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Eusan GMBH Product Description
11.17.5 Eusan GMBH Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Dry Eye Disease Value Chain Analysis
12.2 Dry Eye Disease Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dry Eye Disease Production Mode & Process
12.4 Dry Eye Disease Sales and Marketing
12.4.1 Dry Eye Disease Sales Channels
12.4.2 Dry Eye Disease Distributors
12.5 Dry Eye Disease Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dry Eye Disease Industry Trends
13.2 Dry Eye Disease Market Drivers
13.3 Dry Eye Disease Market Challenges
13.4 Dry Eye Disease Market Restraints
14 Key Findings in The Global Dry Eye Disease Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Dry Eye Disease Market Insights and Forecast to 2027
List of TablesTable 1. Global Dry Eye Disease Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Artificial Tears
Table 3. Major Manufacturers of Anti-inflammatory Drugs
Table 4. Major Manufacturers of Other
Table 5. Global Dry Eye Disease Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Dry Eye Disease Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Dry Eye Disease Sales by Region (2016-2021) & (Kg)
Table 8. Global Dry Eye Disease Sales Market Share by Region (2016-2021)
Table 9. Global Dry Eye Disease Sales by Region (2016-2021) & (Kg)
Table 10. Global Dry Eye Disease Sales Market Share by Region (2022-2027)
Table 11. Global Dry Eye Disease Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Dry Eye Disease Revenue Market Share by Region (2016-2021)
Table 13. Global Dry Eye Disease Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Dry Eye Disease Revenue Market Share by Region (2022-2027)
Table 15. Global Dry Eye Disease Sales by Manufacturers (2016-2021) & (Kg)
Table 16. Global Dry Eye Disease Sales Share by Manufacturers (2016-2021)
Table 17. Global Dry Eye Disease Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Dry Eye Disease Revenue Share by Manufacturers (2016-2021)
Table 19. Dry Eye Disease Price by Manufacturers 2016-2021 (USD/Kg)
Table 20. Global Dry Eye Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Dry Eye Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Disease as of 2020)
Table 22. Dry Eye Disease Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Dry Eye Disease Product Offered
Table 24. Date of Manufacturers Enter into Dry Eye Disease Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dry Eye Disease Sales by Type (2016-2021) & (Kg)
Table 27. Global Dry Eye Disease Sales by Type (2022-2027) & (Kg)
Table 28. Global Dry Eye Disease Sales Share by Type (2016-2021)
Table 29. Global Dry Eye Disease Sales Share by Type (2022-2027)
Table 30. Global Dry Eye Disease Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Dry Eye Disease Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Dry Eye Disease Revenue Share by Type (2016-2021)
Table 33. Global Dry Eye Disease Revenue Share by Type (2022-2027)
Table 34. Dry Eye Disease Price by Type (2016-2021) & (USD/Kg)
Table 35. Global Dry Eye Disease Price Forecast by Type (2022-2027) & (USD/Kg)
Table 36. Global Dry Eye Disease Sales by Application (2016-2021) & (Kg)
Table 37. Global Dry Eye Disease Sales by Application (2022-2027) & (Kg)
Table 38. Global Dry Eye Disease Sales Share by Application (2016-2021)
Table 39. Global Dry Eye Disease Sales Share by Application (2022-2027)
Table 40. Global Dry Eye Disease Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Dry Eye Disease Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Dry Eye Disease Revenue Share by Application (2016-2021)
Table 43. Global Dry Eye Disease Revenue Share by Application (2022-2027)
Table 44. Dry Eye Disease Price by Application (2016-2021) & (USD/Kg)
Table 45. Global Dry Eye Disease Price Forecast by Application (2022-2027) & (USD/Kg)
Table 46. North America Dry Eye Disease Sales by Type (2016-2021) & (Kg)
Table 47. North America Dry Eye Disease Sales by Type (2022-2027) & (Kg)
Table 48. North America Dry Eye Disease Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Dry Eye Disease Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Dry Eye Disease Sales by Application (2016-2021) & (Kg)
Table 51. North America Dry Eye Disease Sales by Application (2022-2027) & (Kg)
Table 52. North America Dry Eye Disease Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Dry Eye Disease Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Dry Eye Disease Sales by Country (2016-2021) & (Kg)
Table 55. North America Dry Eye Disease Sales by Country (2022-2027) & (Kg)
Table 56. North America Dry Eye Disease Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Dry Eye Disease Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Dry Eye Disease Sales by Type (2016-2021) & (Kg)
Table 59. Europe Dry Eye Disease Sales by Type (2022-2027) & (Kg)
Table 60. Europe Dry Eye Disease Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Dry Eye Disease Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Dry Eye Disease Sales by Application (2016-2021) & (Kg)
Table 63. Europe Dry Eye Disease Sales by Application (2022-2027) & (Kg)
Table 64. Europe Dry Eye Disease Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Dry Eye Disease Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Dry Eye Disease Sales by Country (2016-2021) & (Kg)
Table 67. Europe Dry Eye Disease Sales by Country (2022-2027) & (Kg)
Table 68. Europe Dry Eye Disease Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Dry Eye Disease Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Dry Eye Disease Sales by Type (2016-2021) & (Kg)
Table 71. Asia Pacific Dry Eye Disease Sales by Type (2022-2027) & (Kg)
Table 72. Asia Pacific Dry Eye Disease Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Dry Eye Disease Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Dry Eye Disease Sales by Application (2016-2021) & (Kg)
Table 75. Asia Pacific Dry Eye Disease Sales by Application (2022-2027) & (Kg)
Table 76. Asia Pacific Dry Eye Disease Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Dry Eye Disease Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Dry Eye Disease Sales by Region (2016-2021) & (Kg)
Table 79. Asia Pacific Dry Eye Disease Sales by Region (2022-2027) & (Kg)
Table 80. Asia Pacific Dry Eye Disease Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Dry Eye Disease Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Dry Eye Disease Sales by Type (2016-2021) & (Kg)
Table 83. Latin America Dry Eye Disease Sales by Type (2022-2027) & (Kg)
Table 84. Latin America Dry Eye Disease Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Dry Eye Disease Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Dry Eye Disease Sales by Application (2016-2021) & (Kg)
Table 87. Latin America Dry Eye Disease Sales by Application (2022-2027) & (Kg)
Table 88. Latin America Dry Eye Disease Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Dry Eye Disease Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Dry Eye Disease Sales by Country (2016-2021) & (Kg)
Table 91. Latin America Dry Eye Disease Sales by Country (2022-2027) & (Kg)
Table 92. Latin America Dry Eye Disease Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Dry Eye Disease Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Dry Eye Disease Sales by Type (2016-2021) & (Kg)
Table 95. Middle East and Africa Dry Eye Disease Sales by Type (2022-2027) & (Kg)
Table 96. Middle East and Africa Dry Eye Disease Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Dry Eye Disease Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Dry Eye Disease Sales by Application (2016-2021) & (Kg)
Table 99. Middle East and Africa Dry Eye Disease Sales by Application (2022-2027) & (Kg)
Table 100. Middle East and Africa Dry Eye Disease Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Dry Eye Disease Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Dry Eye Disease Sales by Country (2016-2021) & (Kg)
Table 103. Middle East and Africa Dry Eye Disease Sales by Country (2022-2027) & (Kg)
Table 104. Middle East and Africa Dry Eye Disease Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Dry Eye Disease Revenue by Country (2022-2027) & (US$ Million)
Table 106. Santen Pharma Corporation Information
Table 107. Santen Pharma Description and Major Businesses
Table 108. Santen Pharma Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 109. Santen Pharma Dry Eye Disease Product
Table 110. Santen Pharma Recent Developments
Table 111. Novartis Corporation Information
Table 112. Novartis Description and Major Businesses
Table 113. Novartis Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 114. Novartis Dry Eye Disease Product
Table 115. Novartis Recent Developments
Table 116. Llergan Corporation Information
Table 117. Llergan Description and Major Businesses
Table 118. Llergan Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 119. Llergan Dry Eye Disease Product
Table 120. Llergan Recent Developments
Table 121. Takeda Corporation Information
Table 122. Takeda Description and Major Businesses
Table 123. Takeda Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 124. Takeda Dry Eye Disease Product
Table 125. Takeda Recent Developments
Table 126. TRB Chemedica Corporation Information
Table 127. TRB Chemedica Description and Major Businesses
Table 128. TRB Chemedica Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 129. TRB Chemedica Dry Eye Disease Product
Table 130. TRB Chemedica Recent Developments
Table 131. Sun Pharmaceutical Corporation Information
Table 132. Sun Pharmaceutical Description and Major Businesses
Table 133. Sun Pharmaceutical Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 134. Sun Pharmaceutical Dry Eye Disease Product
Table 135. Sun Pharmaceutical Recent Developments
Table 136. Senju Pharmaceutical Corporation Information
Table 137. Senju Pharmaceutical Description and Major Businesses
Table 138. Senju Pharmaceutical Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 139. Senju Pharmaceutical Dry Eye Disease Product
Table 140. Senju Pharmaceutical Recent Developments
Table 141. Sentiss Pharma Corporation Information
Table 142. Sentiss Pharma Description and Major Businesses
Table 143. Sentiss Pharma Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 144. Sentiss Pharma Dry Eye Disease Product
Table 145. Sentiss Pharma Recent Developments
Table 146. Johnson & Johnson Corporation Information
Table 147. Johnson & Johnson Description and Major Businesses
Table 148. Johnson & Johnson Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 149. Johnson & Johnson Dry Eye Disease Product
Table 150. Johnson & Johnson Recent Developments
Table 151. Otsuka Corporation Information
Table 152. Otsuka Description and Major Businesses
Table 153. Otsuka Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 154. Otsuka Dry Eye Disease Product
Table 155. Otsuka Recent Developments
Table 156. Mitotech Corporation Information
Table 157. Mitotech Description and Major Businesses
Table 158. Mitotech Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 159. Mitotech Dry Eye Disease Product
Table 160. Mitotech Recent Developments
Table 161. FCI Corporation Information
Table 162. FCI Description and Major Businesses
Table 163. FCI Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 164. FCI Dry Eye Disease Product
Table 165. FCI Recent Developments
Table 166. Altacor Corporation Information
Table 167. Altacor Description and Major Businesses
Table 168. Altacor Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 169. Altacor Dry Eye Disease Product
Table 170. Altacor Recent Developments
Table 171. Valeant Pharmaceuticals Corporation Information
Table 172. Valeant Pharmaceuticals Description and Major Businesses
Table 173. Valeant Pharmaceuticals Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 174. Valeant Pharmaceuticals Dry Eye Disease Product
Table 175. Valeant Pharmaceuticals Recent Developments
Table 176. United Laboratories Corporation Information
Table 177. United Laboratories Description and Major Businesses
Table 178. United Laboratories Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 179. United Laboratories Dry Eye Disease Product
Table 180. United Laboratories Recent Developments
Table 181. Jianfeng Group Corporation Information
Table 182. Jianfeng Group Description and Major Businesses
Table 183. Jianfeng Group Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 184. Jianfeng Group Dry Eye Disease Product
Table 185. Jianfeng Group Recent Developments
Table 186. Eusan GMBH Corporation Information
Table 187. Eusan GMBH Description and Major Businesses
Table 188. Eusan GMBH Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 189. Eusan GMBH Dry Eye Disease Product
Table 190. Eusan GMBH Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Dry Eye Disease Distributors List
Table 194. Dry Eye Disease Customers List
Table 195. Dry Eye Disease Market Trends
Table 196. Dry Eye Disease Market Drivers
Table 197. Dry Eye Disease Market Challenges
Table 198. Dry Eye Disease Market Restraints
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Disease Product Picture
Figure 2. Global Dry Eye Disease Market Share by Type in 2020 & 2027
Figure 3. Artificial Tears Product Picture
Figure 4. Anti-inflammatory Drugs Product Picture
Figure 5. Other Product Picture
Figure 6. Global Dry Eye Disease Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Drug Stores
Figure 9. Online Pharmacies
Figure 10. Dry Eye Disease Report Years Considered
Figure 11. Global Dry Eye Disease Sales 2016-2027 (Kg)
Figure 12. Global Dry Eye Disease Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Dry Eye Disease Revenue 2016-2027 (US$ Million)
Figure 14. Global Dry Eye Disease Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Dry Eye Disease Sales Market Share by Region (2016-2021)
Figure 16. Global Dry Eye Disease Sales Market Share by Region (2022-2027)
Figure 17. North America Dry Eye Disease Sales YoY (2016-2027) & (Kg)
Figure 18. North America Dry Eye Disease Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Dry Eye Disease Sales YoY (2016-2027) & (Kg)
Figure 20. Europe Dry Eye Disease Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Dry Eye Disease Sales YoY (2016-2027) & (Kg)
Figure 22. Asia-Pacific Dry Eye Disease Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Dry Eye Disease Sales YoY (2016-2027) & (Kg)
Figure 24. Latin America Dry Eye Disease Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Dry Eye Disease Sales YoY (2016-2027) & (Kg)
Figure 26. Middle East & Africa Dry Eye Disease Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Dry Eye Disease Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Dry Eye Disease Revenue in 2020
Figure 29. Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Dry Eye Disease Sales Market Share by Type (2016-2027)
Figure 31. Global Dry Eye Disease Revenue Market Share by Type (2016-2027)
Figure 32. Global Dry Eye Disease Sales Market Share by Application (2016-2027)
Figure 33. Global Dry Eye Disease Revenue Market Share by Application (2016-2027)
Figure 34. North America Dry Eye Disease Sales Market Share by Type (2016-2027)
Figure 35. North America Dry Eye Disease Revenue Market Share by Type (2016-2027)
Figure 36. North America Dry Eye Disease Sales Market Share by Application (2016-2027)
Figure 37. North America Dry Eye Disease Revenue Market Share by Application (2016-2027)
Figure 38. North America Dry Eye Disease Sales Share by Country (2016-2027)
Figure 39. North America Dry Eye Disease Revenue Share by Country (2016-2027)
Figure 40. U.S. Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Dry Eye Disease Sales Market Share by Type (2016-2027)
Figure 43. Europe Dry Eye Disease Revenue Market Share by Type (2016-2027)
Figure 44. Europe Dry Eye Disease Sales Market Share by Application (2016-2027)
Figure 45. Europe Dry Eye Disease Revenue Market Share by Application (2016-2027)
Figure 46. Europe Dry Eye Disease Sales Share by Country (2016-2027)
Figure 47. Europe Dry Eye Disease Revenue Share by Country (2016-2027)
Figure 48. Germany Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 49. France Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Dry Eye Disease Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Dry Eye Disease Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Dry Eye Disease Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Dry Eye Disease Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Dry Eye Disease Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Dry Eye Disease Revenue Share by Region (2016-2027)
Figure 59. China Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 62. India Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 68. Philippines Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Dry Eye Disease Sales Market Share by Type (2016-2027)
Figure 70. Latin America Dry Eye Disease Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Dry Eye Disease Sales Market Share by Application (2016-2027)
Figure 72. Latin America Dry Eye Disease Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Dry Eye Disease Sales Share by Country (2016-2027)
Figure 74. Latin America Dry Eye Disease Revenue Share by Country (2016-2027)
Figure 75. Mexico Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Dry Eye Disease Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Dry Eye Disease Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Dry Eye Disease Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Dry Eye Disease Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Dry Eye Disease Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Dry Eye Disease Revenue Share by Country (2016-2027)
Figure 84. Turkey Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 86. U.A.E Dry Eye Disease Revenue (2016-2027) & (US$ Million)
Figure 87. Dry Eye Disease Value Chain
Figure 88. Dry Eye Disease Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
